RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis

Recruiting N/A Interventional Study
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
200 (estimated)
Sponsor
University of Alberta · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
We are studying the effect of a mind-body treatment for people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with or without Long COVID (LC). Our team recognizes that ME/CFS and Long COVID are serious, debilitating, biomedical conditions. ME/CFS can affect many different parts of the body, such as the nervous system, immune system, and metabolism. It is hypothesized that centra…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18 years or older; * Individuals diagnosed with ME/CFS, according to the Institute of Medicine (2015) criteria, for more than six months. Exclusion Criteria: Individuals who: 1) are too ill to participate; 2) lack reliable internet; 3) cannot communicate in English; 4) P…
Contacts

MILES RCT team

780-680-8907

rctmiles@ualberta.ca

CONTACT